Nano-sized vesicles with ACE2 receptor could prevent, treat infection from current and future strains of SARS-CoV-2 [20-01-2022]
Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.
